Business Wire

Bahrain to Host Global Entrepreneurship Congress 2019

Jaa

Bahrain named host country for the Global Entrepreneurship Congress in 2019 at a high-profile event at the UN HQ in NY, confirming the country’s position as a business-friendly nation and an international leader in the field of entrepreneurship and business innovation.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171115006326/en/

UN HQ: HE Sh. Abdulla bin Ahmed Al Khalifa Undersecretary for International Affairs speaks after ann ...

UN HQ: HE Sh. Abdulla bin Ahmed Al Khalifa Undersecretary for International Affairs speaks after announcement of Kingdom of Bahrain as Host for GEC 2019 (Photo: AETOSWire)

The annual global event, hosted by countries including the US, UK, China, Italy, Brazil and Russia, brings thousands of entrepreneurs, investors, researchers, and policymakers from more than 170 countries to identify new ways of helping founders start and scale new ventures around the world.

“We are perfectly placed to host this event. With our history of proactively developing and enacting programs designed to empower Bahrainis and new enterprises. The event will bring together Bahrain’s best and brightest business minds, to provide a platform for thought leadership and greater cooperation between Bahrain and its international partners,” Tamkeen’s CEO Dr. Ebrahim Janahi said.

Entrepreneurship and business innovation are integral components in the larger Bahrain Economic Vision2030. SMEs now contribute nearly 30% of nominal GDP, and provide jobs for nearly 73% of private sector employees.

Bahrain is regarded as an attractive destination to international businesses for its well-established, trusted and transparent regulatory environment. Ranking first within the GCC for fiscal health, second for judicial effectiveness and third in the Economic Freedom Index2017.

Bahrain Economic Development Board CEO, Khalid AlRumaihi, added: “It’s an honor and privilege to welcome the global entrepreneurial community to Bahrain. From pearl fishing to the early discovery of oil, we recognized the importance of diversifying the economy and have made great strides in the financial, telecommunications, and logistics sectors. Our sustained efforts in the private sector are placing Bahrain among the most advanced countries in the region, an ideal gateway to the $1.6 trillion Gulf market.”

About Tamkeen:

Tamkeen is a semi-government organization in Bahrain established in 2006 under Law Number (57) as part of the country’s national reform initiatives, with the task of making the private sector as the key driver of sustainable economic development.

Underpinned by 3 strategic pillars – enhancing quality, serving customers, and achieving results - the organization provides an integrated range of programs to create a solid foundation for a modern economy. To date, its programs have served more than 140,000 Bahrainis and businesses. www.tamkeen.bh

*Source: AETOSWire

Contact information

The National Communication Centre, Kingdom of Bahrain
Aziza Salman, +97313111138, +97336887887
a.salman@ncc.gov.bh

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 201711.12.2017 16:00Tiedote

2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against cancer. External partnerships complement Boehringer Ingelheim’s two-pronged research strategy – investigating both cancer cell-directed therapies and immune cell-directed therapies. This multi-faceted approach offers the potential to bring innovative opportunities to the Boehringer Ingelheim oncology portfolio and novel therapies to patients. “Immuno-oncology is radically shifting the research and treatment landscape in oncology. We believe that the greatest success in difficult-to-treat cancers will be achieved with immuno-oncology and its combination with cancer cell directed therapy, which is why we are committing significant resources in both areas,” said Jonathon Sedgwick, Ph.D., Vice

Valence Advises SK Capital on Its Acquisition of ICL’s Fire Safety and Oil Additives Businesses11.12.2017 15:47Tiedote

The Valence Group acted as lead financial advisor to SK Capital Partners on its announced acquisition of the Fire Safety and Oil Additives businesses of Israel Chemicals Ltd. (“ICL”) for approximately $1 billion. The transaction is expected to close during the first half of 2018. The Businesses, headquartered in St. Louis, Missouri, have global operations and are market leaders in each of their segments. The ICL Fire Safety business is a formulator and manufacturer of fire management chemicals. Its Phos-Chek fire retardants, Class A and B foams, and water enhancing gels are the world’s leading chemical solutions for managing wildland, military, industrial and municipal fires, and are used in partnership with fire management agencies across the globe. The ICL Oil Additives business provides high quality phosphorus pentasulfide used in the preparation of ZDDP-based lubricant additives, i

Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care11.12.2017 13:18Tiedote

Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the European launch of MolecuLight i:X TM, the easy to use, handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of potentially harmful bacteria in wounds.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005434/en/ Currently wound assessments are made with the naked eye which can lack the accuracy required to most effectively guide clinical decision making.4 Using fluorescence, MolecuLight i:X quickly, safely, and easily visualises potentially harmful bacteria1,2,3 in wounds which may otherwise lack signs or symptoms of infection. It enhances a clinician’s ability to choose the right therapy, at the right time for their patient1,

Dr Amal Al Qubaisi Wins Parliamentarian Excellence Award as Best President of Arab Parliament11.12.2017 12:41Tiedote

The Arab Inter-Parliamentary Union (AIPU) has honored Her Excellency Dr Amal Al Qubaisi, Speaker of the Federal National Council (FNC) – the United Arab Emirates parliament, with the Parliamentarian Excellence Award in the Presidents of Arab Parliaments category. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005411/en/ Her Excellency Dr Amal Al Qubaisi, Speaker of the Federal National Council (FNC) – the UAE parliament (Photo: AETOSWire) The award honors Al Qubaisi as ‘first female leader of a parliament in the Arab world’, celebrating her achievements on a national, regional and global scale, as well as the accomplishments made by FNC under her leadership. It also acknowledges the pioneering parliamentarian initiatives, projects and programs she has spearheaded and her significant contr

Top UK university hospital unveils data that support the use of rapid infusion for Truxima® (CT-P10, biosimilar rituximab) in patients with advanced-stage follicular lymphoma11.12.2017 11:00Tiedote

New data from University College London Hospitals NHS Foundation Trust (UCLH) on the safety and tolerability of rapid infusion of CT-P10 were presented this weekend at the 59th American Society of Hematology (ASH) Annual Meeting. The results showed that rapid infusion of CT-P10 was well-tolerated across all patient groups and patients could be safely switched from reference rituximab to CT-P10 without reverting to slower infusion rates1. The independent study examined the infusion-related reactions (IRRs) in three different patient groups: rituximab naive, those switching directly from reference rituximab to CT-P10, and those that received their last dose of reference rituximab at least 6 months prior to the study.1 The administration of rituximab is associated with IRRs which occur most frequently during the first infusion. To reduce the risk of IRRs, it is the man

Financial Market Regulator Grants EU Payment License to DIMOCO Payment Services11.12.2017 11:00Tiedote

The Austrian Financial Market Authority (FMA) granted a license under the Payment Service Act to DIMOCO Payment Services . The awarded license allows DIMOCO Payment Services to contribute to the payment value chain, offering merchants a single technical interface and a unified clearing & settlement process for many payment methods, including credit cards, online bank transfers, SEPA and direct debit cards. “We differ from most PSPs in the global payments ecosystem with our personal touch,” said Boris Kersten, Managing Director of DIMOCO Payment Services. “We proactively and personally monitor the overall payment process. In addition to monitoring individual transactions, we make recommendations and take actions to decrease chargebacks and fraudulent transactions. This process is not simply left to algorithms, the human element is added to the mix resulting in the protec

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme